Biocon receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biocon Ltd. (BION)
Biocon Ltd. stock price live, this page displays NSE BION stock exchange data. View the BION premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biocon Ltd. real time stock price chart below.
What Is the Biocon Ltd. Stock Price Today?
The Biocon Ltd. stock price today is 426.00.
What Is the Stock Symbol for Biocon Ltd.?
The stock ticker symbol for Biocon Ltd. is BION.
Is BION the Same as $BION?
$BION is a common way to refer to the Biocon Ltd. ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Biocon Ltd. Trade On?
Biocon Ltd. is listed and trades on the NSE stock exchange.
Is Biocon Ltd. a Good Stock to Buy?
Determining whether Biocon Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Biocon Ltd. share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BION quote. (ISIN: INE376G01013)
What Is the Biocon Ltd. Stock Price Today?
The Biocon Ltd. stock price today is 426.00.
What Is the Stock Symbol for Biocon Ltd.?
The stock ticker symbol for Biocon Ltd. is BION.
Is BION the Same as $BION?
$BION is a common way to refer to the Biocon Ltd. ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Biocon Ltd. Trade On?
Biocon Ltd. is listed and trades on the NSE stock exchange.
Is Biocon Ltd. a Good Stock to Buy?
Determining whether Biocon Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Biocon Ltd. share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BION quote. (ISIN: INE376G01013)
426.00
-0.10(-0.02%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
420.30
426.00
52 wk Range
337.05
447.15
BION is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
420.30426.00
52 wk Range
337.05447.15
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.12%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.12%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BION Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
434.32
Upside
+1.95%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Biocon receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Biocon receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Biocon receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Biocon receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
9 Buy
3 Hold
7 Sell
Ratings:
19 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 434.32
(+1.95% Upside)
Biocon Ltd. Earnings Call Summary for Q1/2027
- Biocon Q1 FY2027 revenue rose 10% YoY; group EBITDA hit INR 902 crore at 21% margin; net profit before exceptionals surged 245% to INR 145 crore.
- Biopharmaceuticals revenue grew 17% to INR 2,855 crore; generics revenue jumped 21% to INR 760 crore with margin expansion of 250+ basis points.
- Finance costs fell 23% YoY to INR 213 crore; net debt rose INR 1,100 crore sequentially due to inventory build for anticipated H2 growth.
- Management expects stronger H2 driven by five core biosimilars and new launches; pledged all free cash flow to debt reduction and one new product annually.
- Syngene revenue declined 16% YoY; FY2027 deemed transition year with low single-digit rupee revenue decline expected before H2 recovery begins.
Last Updated: 08/06/2026, 01:41 AM
Read Full TranscriptBiocon investor slides for Q1/2027
Last Update: Aug 06, 2026
See full investor slides
Earnings
Latest Release
Aug 04, 2026
EPS / Forecast
0.87 / 0.91
Revenue / Forecast
43.36B / 44.77B
Compare BION to Peers and Sector
Metrics to compare | BION | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIONPeersSector | |
|---|---|---|---|---|
P/E Ratio | 139.3x | 35.9x | −0.4x | |
PEG Ratio | 28.05 | 0.38 | 0.00 | |
Price / Book | 2.0x | 3.8x | 2.6x | |
Price / LTM Sales | 4.0x | 4.2x | 3.1x | |
Upside (Analyst Target) | 0.2% | 5.5% | 48.2% | |
Fair Value Upside | Unlock | −1.8% | 5.8% | Unlock |
Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, central nervous system, anti-cancer/oncology, multiple sclerosis, immunosuppressants, and specialty molecules; and biosimilars products for oncology, diabetes, and immunology therapeutic areas. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal health, consumer goods, and specialty chemical industries, as well as academic institutions, non-profit organizations, and government agencies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Biocon (BION) Stock Price Today?
The Biocon stock price today is 426.00 INR.
What Stock Exchange Does Biocon Trade On?
Biocon is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Biocon?
The stock symbol for Biocon is "BION."
Does Biocon Pay Dividends? What’s The Current Dividend Yield?
The Biocon dividend yield is 0.12%.
What Is the Biocon Market Cap?
As of today, Biocon market cap is 689.91B INR.
What Is Biocon's Earnings Per Share (TTM)?
The Biocon EPS (TTM) is 3.37.
When Is the Next Biocon Earnings Date?
Biocon will release its next earnings report on Nov 17, 2026.
From a Technical Analysis Perspective, Is BION a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Biocon Stock Split?
Biocon has split 3 times.
How Many Employees Does Biocon Have?
Biocon has 16447 employees.
What is the current trading status of Biocon (BION)?
As of Aug 11, 2026, Biocon (BION) is trading at a price of 426.00 INR, with a previous close of 426.00 INR. The stock has fluctuated within a day range of 420.30 INR to 426.00 INR, while its 52-week range spans from 337.05 INR to 447.15 INR.
What Is Biocon (BION) Price Target According to Analysts?
The average 12-month price target for Biocon is 434.32 INR, with a high estimate of 534 INR and a low estimate of 290 INR. 9 analysts recommend buying the stock, while 7 suggest selling, leading to an overall rating of Neutral. The stock has an +1.95% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.